Thymidine Phosphorylase Profiles in Nonmalignant and Malignant Pancreatic Tissue. Potential Therapeutic Role of Capecitabine on Tumoral and Endothelial Cells and Tumor-Infiltrating Macrophages

References

• Brown, N.S.; Bicknell, R. Thymidine phosphorylase, 2-deoxi-d-ribose and angiogenesis. Biochem. J. 1998, 334 (1), 1–8. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Friedkin, M.; Roberts, D. The enzymatic synthesis of nucleosides. I. Thymidine phosphorylase in mammalian tissue. J. Biol. Chem. 1954, 207 (1), 245–256. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Friedkin, M.; Roberts, D. The enzymatic synthesis of nucleosides. II. Thymidine and related pyrimidine nucleosides. J. Biol. Chem. 1954, 207 (1), 257–266. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Blank, J. G.; Hoffee, P.A. Purification and properties of thymidine phosphorylase from Salmonella typhimurium. Arch. Biochem. Biophys. 1975, 168 (1), 259–265. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Kubilus, J.; Lee, L. D.; Baden, H.P. Purification of thymidine phosphorylase from human amniochorion. Biochim. Biophys. Acta 1978, 527 (1), 221–228. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Voytek, P. Purification of thymidine phosphorylase from Escherichia coli and its photoinactivation in the presence of thymine, thymidine, and some halogenated analogs. J. Biol. Chem. 1975, 250 (10), 3660–3665. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Patterson, A. V.; Talbot, D.C.; Stratford, I.J.; Harris, A.L. Thymidine phosphorylase moderates thymidine-dependent rescue after exposure to the thymidylate synthase inhibitor ZD1694 (Tomudex) in vitro. Cancer Res. 1998, 58 (13), 2737–2740. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Engels, K.; Fox, S. B.; Witehouse, R.M.; Gatter, K.C.; Harris, A.L. Up-regulation of thymidine phosphorylase expression is associated with a discrete pattern of angiogenesis in ductal carcinomas in situ of the breast. J. Pathol. 1997, 182 (4), 414–420. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Alcade, R.E.; Terakado, N.; Otsuki, K.; Matsumara, T. Angiogenesis and expression of platelet-derived endothelial cell growth factor in oral squamous cell carcinoma. Oncology 1997, 54 (4), 324–328. [CSA]
   PubMedGoogle Scholar
• Ranieri, G.; Labriola, A.; Achille, G.; Florio, G.; Zito, A.F.; Grammatica, L.; Paradiso, A. Microvessel density, mast cell density and thymidine phosphorylase expression in oral squamous carcinoma. Int. J. Oncol. 2002, 21 (6), 1317–1323., [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ranieri, G.; Gasparini, G. Metastasis Research Protocols; Brooks Susan Press: OxfordUK, 2001; 94–114.
   Google Scholar
• Nakajima, Y.; Gotanda, T.; Uchimiya, H.; Furukawa, T.; Haraguchi, M.; Ikeda, R.; Sumizawa, T.; Yoshida, S.; Akiyama, H. Inhibition of metastasis of tumor cells overexpressing thymidine phosphorylase by 2-deoxy-L-ribose. Cancer Res. 2004, 64 (5), 1794–1801. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sengupta, S.; Sellers, L. A.; Matheson, H.B.; Fan, T.P. Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms. Br. J. Pharmacol. 2003, 139 (2), 219–231. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Moghaddam, A.; Zhang, H.T.; Fan, T.P.D.; Hu, D.E.; Lees, V.C.; Turley, H.; Fox, S.B.; Gatter, K.C.; Harris, A.L.; Bicknell, R. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc. Natl. Acad. Sci. U. S. A. 1995, 92 (4), 998–1002. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Fujimoto, K.; Hosotani, R.; Wada, M.; Lee, J.U.; Koshiba, T.; Miyamoto, Y.; Tsuji, S.; Nakajima, S.; Doi, R.; Imamura, M. Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis. Eur. J. Cancer 1998, 34 (9), 1439–1447. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kuwahara, K.; Sasaki, T.; Kuwada, Y.; Murakami, M.; Yamasaki, S.; Chayama, K. Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival. Pancreas 2003, 26 (4), 344–349. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fujioka, S.; Yoshida, K.; Yanagisawa, S.; Kawakami, M.; Aoki, T.; Yamazaki, Y. Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival. Cancer 2001, 92 (7), 1788–1797. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Minari, Y.; Nio, Y.; Hirahara, N.; Dong, M. Heterogeneic distribution of thymidine phosphorylase between primary tumors and metastatic lesions of human pancreatic ductal carcinoma: implications for the efficacy of chemotherapy with 5-FU or its derivatives. Cancer Chemother. Pharmacol. 2001, 47 (5), 415–422. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Takao, S.; Takebayashi, Y.; Che, X.; Shinchi, H.; Natsugoe, S.; Miyadera, K.; Yamada, Y.; Akiyama, S.; Aikou, T. Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas. Clin. Cancer Res. 1998, 4 (7), 1619–1624. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Osada, S.; Saji, S.; Takahashi, T. A case report of papilla Vater carcinoma showing positive expression of thymidine phosphorylase. Hepatogastroenterology 2004, 51 (56), 375–377. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Biganzoli, L.; Martin, M.; Twelves, C. Moving forward with capecitabine: a glimpse of the future. Oncologist 2002, 7 (6), 29–35. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Twelves, C. Vision of the future: capecitabine. Oncologist 2001, 6 (4), 35–39. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Malet-Martino, M.; Martino, R. Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review. Oncologist 2002, 7 (4), 288–323. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Takebayashi, Y.; Yamada, K.; Miyadera, K.; Sumizawa, T.; Furukawa, T.; Kinoshita, F.; Aoki, D.; Okumura, H.; Yamada, Y.; Akiyama, S.; Aikou, T. The activity and expression of thymidine phosphorylase in human solid tumours. Eur. J. Cancer 1996, 32A (7), 1227–1232. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Takebayashi, Y.; Akiyama, S.; Akiba, S.; Yamada, K.; Miyadera, K.; Sumizawa, T.; Yamada, Y.; Murata, F.; Aikou, T. Clinicopathologic and prognosticsignificance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J. Natl. Cancer Inst. 1996, 88 (16), 1110–1117. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Pentheroudakis, G.; Twelves, C. The rational development of capecitabine from the laboratory to the clinic. Anticancer Res. 2002, 22 (6B), 3589–3596. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Morita, T.; Matsuzaki, A.; Suzuki, K.; Tokue, A. Role of thymidine phosphorylase in biomodulation of fluoropyrimidines. Curr. Pharm. Biotechnol. 2001, 2 (3), 257–267. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Sobin, L. H.; Fleming, I.D. TNM classification of malignant tumours, 5th Ed. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997, 80 (9), 1803–1804. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Ranieri, G.; Patruno, R.; Fiore, G.; Saponaro, G.; Paradiso, A.; Grammatica, L. Thymidine phosphorylase over-expression in oral squamous carcinoma tissue as a potential target of capecitabine. Lett. Drug Design Disc. 2004, 1, 45–49.
   Google Scholar
• Weidner, N.; Semple, J.P.; Welch, W.R.; Folkman, J. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N. Engl. J. Med. 1991, 324 (1), 1–8. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ranieri, G.; Passantino, L.; Patruno, R.; Passantino, G.; Jirillo, F.; Catino, A.; Mattioli, V.; Gadaleta, C.; Ribatti, D. The dog mast cell tumour as a model to study the relationship between angiogenesis, mast cell density and tumour malignancy. Oncol. Rep. 2003, 10 (5), 1189–1193. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• van Overveld, F. J.; Bruijnzeel, P.L.; Kreukniet, J.; Raaijmakers, J.A.; Terpstra, G.K. The isolation of inflammatory cells from normal human lung tissue. Int. J. Tissue React. 1987, 9 (1), 61–67. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Saxena, R. K.; Weissman, D.; Simpson, J.; Lewis, D.M. Murine model of BCG lung infection: dynamics of lymphocyte subpopulations in lung interstitium and tracheal lymph nodes. Bioscience 2002, 27 (2), 143–153.
   Google Scholar
• Wakeham, J.; Wang, J.; Magram, J.; Croitoru, K.; Harkness, R.; Dunn, P.; Zganiacz, A.; Xing, Z. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guerin in IL-12-deficient mice. J. Immunol. 1998, 160 (12), 6101–6111. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Caradonna, L.; Mastronardi, M.L.; Magrone, T.; Cozzolongo, R.; Cuppone, R.; Manghisi, O.G.; Caccavo, D.; Pellegrino, N.M.; Amoroso, A.; Jirillo, E.; Amati, L. Biological and clinical significance of endotoxemia in the course of hepatitis C virus infection. Curr. Pharm. Des. 2002, 8 (11), 995–1005. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Sengupta, S.; Sellers, L. A.; Matheson, H.B.; Fan, T.P. Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms. Br. J. Pharmacol. 2003, 139 (2), 219–231. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Ishikawa, F.; Miyazono, K.; Hellman, U.; Drexler, H.; Wernstedt, C.; Hagiwara, K.; Usuki, K.; Takaku, F.; Risau, W.; Heldin, C. H. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989, 338 (6216), 557–562. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Khan, A. W.; Dhillon, A.P.; Hutchins, R.; Abraham, A.; Shah, S.R.; Snooks, S.; Davidson, B.R. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. Eur. J. Surg. Oncol. 2002, 28 (6), 637–644. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Kuehn, R.; Lelkes, P. I.; Bloechle, C.; Niendorf, A.; Izbicki, J.R. Angiogenesis, angiogenic growth factors, and cell adhesion molecules are upregulated in chronicpancreatic diseases: angiogenesis in chronic pancreatitis and in pancreatic cancer. Pancreas 1999, 18 (1), 96–103. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Esposito, I.; Menicagli, M.; Funel, N.; Bergmann, F.; Boggi, U.; Mosca, F.; Bevilacqua, G.; Campani, D. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J. Clin. Pathol. 2004, 57 (6), 630–636. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Giatromanolaki, A.; Koukourakis, M. I.; Comley, M.; Kaklamanis, L.T.H.; O'Byrne, K.; Harris, A.L.; Gatter, K.C. Platelet-derived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancer. J. Pathol. 1997, 181 (2), 196–199. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Nagaoka, H.; Iino, Y.; Takei, H.; Morishita, Y. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in macrophages correlates with tumor angiogenesis and prognosis in invasive breast cancer. Int. J. Oncol. 1998, 13 (3), 449–454. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Zhu, G. H.; Schwartz, E.L. Expression of the angiogenic factor thymidine phosphorylase in THP-1 monocytes: induction by autocrine tumor necrosis factor-alpha and inhibition by aspirin. Mol. Pharmacol. 2003, 64 (5), 1251–1258. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Hotchkiss, K. A.; Ashton, A.W.; Klein, R.S.; Lenzi, M.L.; Zhu, G.H.; Schwartz, E.L. Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration. Cancer Res. 2003, 63 (2), 527–533. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Toi, M.; Hoshina, S.; Taniguchi, T.; Yamamoto, Y.; Ishitsuka, H.; Tominaga, T. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int. J. Cancer 1995, 64 (2), 79–82. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fox, S. B.; Westwood, M.; Moghaddam, A.; Comley, M.; Turley, H.; Whitehouse, R.M.; Bicknell, R.; Gatter, K.C.; Harris, A.L. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br. J. Cancer 1996, 73 (3), 275–280. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Nagaoka, H.; Iino, Y.; Takei, H.; Morishita, Y. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in macrophages correlates with tumor angiogenesis and prognosis in invasive breast cancer. Int. J. Oncol. 1998, 13 (3), 449–454. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Kerbel, R.S.; Viloria-Petit, A.; Rak, J. ‘Accidental’ anti-angiogenic drugs: anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples. Eur. J. Cancer 2000, 36 (10), 1248–1257. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar